Through the VEGFR2-Akt-eNOS pathway, it promotes angiogenesis (new blood vessels), ensuring that the metabolically active fibroblasts stimulated by GHK-Cu receive the oxygen and nutrients needed for protein synthesis
Mechanisms : Reduces TNF-alpha (key inflammatory marker) Lowers IL-6 and IL-1 (inflammatory cytokines) Modulates immune cell activity Protects tissues from inflammatory damage Applications : Joint pain (arthritis, synovitis) Inflammatory bowel conditions Autoimmune conditions (supportive therapy) General systemic inflammation Protocol : 1-2mg daily injectable, 8-12 weeks Expected results : 40-60% inflammation reduction, improved symptoms, better quality of life
and Fromme, J.C
A good example is a review published in 2003 in Endocrine Reviews , in which the authors note the importance of [growth hormone] and IGF systems in normal skin homeostasis. They specifically mention the role that growth hormone plays in collagen synthesis and the effect that IGF has on skin cell proliferation
The lack of solid clinical evidence on long-term safety, especially for ongoing use, creates uncertainty about potential interactions